Loncar Cancer Etf Forecast - Market Facilitation Index

CNCR Etf  USD 13.56  0.34  2.57%   
Loncar Etf Forecast is based on your current time horizon.
  
Loncar Cancer Immunotherapy has current Market Facilitation Index of 0.42. Market Facilitation Index is simply a difference between period high and low prices divided by period trading volume.
Check Loncar Cancer VolatilityBacktest Loncar CancerInformation Ratio  

Loncar Cancer Trading Date Momentum

On November 25 2024 Loncar Cancer Immunotherapy was traded for  13.56  at the closing time. The top price for the day was 13.70  and the lowest listed price was  13.28 . There was no trading activity during the period 0.0. Lack of trading volume on November 25, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.06% .
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
Compare Loncar Cancer to competition

Other Forecasting Options for Loncar Cancer

For every potential investor in Loncar, whether a beginner or expert, Loncar Cancer's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Loncar Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Loncar. Basic forecasting techniques help filter out the noise by identifying Loncar Cancer's price trends.

Loncar Cancer Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Loncar Cancer etf to make a market-neutral strategy. Peer analysis of Loncar Cancer could also be used in its relative valuation, which is a method of valuing Loncar Cancer by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Loncar Cancer Immuno Technical and Predictive Analytics

The etf market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Loncar Cancer's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Loncar Cancer's current price.

Loncar Cancer Market Strength Events

Market strength indicators help investors to evaluate how Loncar Cancer etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Loncar Cancer shares will generate the highest return on investment. By undertsting and applying Loncar Cancer etf market strength indicators, traders can identify Loncar Cancer Immunotherapy entry and exit signals to maximize returns.

Loncar Cancer Risk Indicators

The analysis of Loncar Cancer's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Loncar Cancer's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting loncar etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Loncar Cancer

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Loncar Cancer position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Loncar Cancer will appreciate offsetting losses from the drop in the long position's value.

Moving together with Loncar Etf

  0.61XLV Health Care SelectPairCorr
  0.66VHT Vanguard Health CarePairCorr
  0.87IBB iShares Biotechnology ETFPairCorr
  0.87XBI SPDR SP BiotechPairCorr

Moving against Loncar Etf

  0.44RSPY Tuttle Capital ManagementPairCorr
  0.44MEME Roundhill InvestmentsPairCorr
  0.36DSJA DSJAPairCorr
The ability to find closely correlated positions to Loncar Cancer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Loncar Cancer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Loncar Cancer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Loncar Cancer Immunotherapy to buy it.
The correlation of Loncar Cancer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Loncar Cancer moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Loncar Cancer Immuno moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Loncar Cancer can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Loncar Cancer Immuno is a strong investment it is important to analyze Loncar Cancer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Loncar Cancer's future performance. For an informed investment choice regarding Loncar Etf, refer to the following important reports:
Check out Historical Fundamental Analysis of Loncar Cancer to cross-verify your projections.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
The market value of Loncar Cancer Immuno is measured differently than its book value, which is the value of Loncar that is recorded on the company's balance sheet. Investors also form their own opinion of Loncar Cancer's value that differs from its market value or its book value, called intrinsic value, which is Loncar Cancer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Loncar Cancer's market value can be influenced by many factors that don't directly affect Loncar Cancer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Loncar Cancer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Loncar Cancer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Loncar Cancer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.